Safety and Efficacy Study of hAESCs Therapy for aGVHD
Clinical trial NCT06164288 · UNKNOWN
Trial details
- NCT number
- NCT06164288
- Sponsor
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2024-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.